Press release
Pharmacogenomics Market Potential, Dynamics, Share Value, Size Analysis and Outlook to 2023 – by Teva Pharmaceutical Industries Ltd., Assurex Health Inc., Future Science Group, Pathway Genomics, etc
Pharmacogenomics Market Report include on MarketResearchFuture.com with exhaustive Study. The report aims to provide an overview of Pharmacogenomics Market Report. The report provides key statistics on the market status. Global Forecast till 2023.The Global Pharmacogenomics Market is presumed to register 5.8% CAGR during the forecast period (2017-2023) owing to the rising prevalence of several infectious and non-infectious diseases, asserts Market Research Future (MRFR). Pharmacogenomics refers to the study of inherited variations in the human genes that affect an individual’s reaction to a specific drug. Various genetic tests are performed in pharmacogenomics to determine targeted drug therapies and treatment procedures to be adopted in order to reduce side effects and improve the results.
Drivers and Constraints Impacting the Market
With the growing prevalence of various infectious and non-infectious diseases, growing demand for personalized drugs, increasing usage in drug discovery process, and increasing awareness about the benefits of pharmacogenomics are stimulating the market during the assessment period. Pharmacogenomics offers effective treatment therapeutics which is both reliable and safe. Thus, increasing awareness about its benefits is anticipated to augment the market growth in the coming years. Also, innovation and rapid advancements of new healthcare technologies such as High Throughput Screening (HTS), next-generation sequencing, and Digital Polymerase Chain Reaction (PCR) are further influencing the market growth.
On the flip side, lack of consistency in pharmacogenomics and lack of awareness are some of the key factors considered to impede the market growth in the coming years.
Get Exclusive PDF Sample Copy of Report @ https://www.marketresearchfuture.com/sample_request/1177
Latest Industry Updates
October 31, 2018: The U.S. Food and Drug Administration has recently announced that they have approved the marketing of 23andMe’s reports on pharmacogenetics. The genetic-testing company claims are designed to assess whether the genetics will affect an individual’s ability to metabolize certain drugs which include antidepressants.
Nov 2017: Myriad Genetics, Inc., announced positive results from a double-blind, multi-center, randomized controlled trial assessing the impact of the GeneSight Psychotropic test (GeneSight) on psychiatric treatment response in 1,200 patients with major depressive disorder. GeneSight is one of the leading pharmacogenomics test to help guide medication selection for mental health disorders.
Global Pharmacogenomics Market - Competitive Analysis
Pharmacogenomics in recent years has used a new generation of technology approaches that has led to a revolution in the understanding of disease susceptibility and pathophysiology, providing enormous potential for novel therapeutic strategies.
However, with companies aiming to capture a considerable share of the market segment as early as possible, they are competing and experimenting with various advantage points. The best long-term growth opportunities for this sector can be captured by ensuring ongoing process improvements and financial flexibility to invest in the best strategies.
The noteworthy players operating the global market are Teva Pharmaceutical Industries Ltd. (Israel), Assurex Health Inc. (U.S.), Future Science Group (U.S.), Pathway Genomics (U.S.), Myriad Genetics Inc. (U.S.), GeneDx. (U.S.), GeneTech (U.S.), 23andMe Inc. (U.S.), and others.
Global Pharmacogenomics Market: Segmental Analysis
The global pharmacogenomics market has been segmented on the basis of application, technology, end-user, and region.
By mode of technology, the global pharmacogenomics market has been segmented into sequencing, microarray, polymerase chain reaction, and others. Among these, the sequencing segment has been sub-segmented into pyrosequencing, Sanger sequencing, next-generation sequencing, and others.
By mode of application, the global pharmacogenomics market has been segmented into cardiology, oncology, neurological disorders, and others. Among these, the oncology segment has been sub-segmented into lung cancer, breast cancer, and others.
By mode of end-users, the global pharmacogenomics market has been segmented into research organizations, hospitals, academic institute, and others.
Regional Analysis of Pharmacogenomics Market
Geographically, the pharmacogenomics market span across regions namely, Europe, America, Asia Pacific, and the Middle East and Africa.
The American region is considered to dominate the global pharmacogenomics market and is estimated to maintain its dominance during the assessment period. The growth is attributed to the presence of developed countries such as Canada and the U.S. along with a well-developed healthcare sector. Also, growing number of patients suffering from cardiovascular diseases have stimulated the growth of the market in this region.
The European region is considered to be the second largest market owing to the availability of funds for research and development activities. Moreover, the presence of huge patient population is influencing the market positively. With the presence of developed countries such as France and Germany, the market is likely to flourish during the review period.
Asia Pacific is the fastest growing region owing to the continuously developing economies such as China and India and presence of huge patient population. Meanwhile, the Middle East and Africa hold the least share owing to the presence of poor economy, strict government policies, and low per capita healthcare expenditure in this region.
Browse Complete Report @ https://www.marketresearchfuture.com/reports/pharmacogenomics-market-1177
Some Brief Table of Content
Chapter 1. Report Prologue
Chapter 2. Market Introduction
2.1 Definition
2.2 Scope Of The Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations
Chapter 3. Research Methodology
3.1 Introduction
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
Chapter 4. Market Dynamics
4.1 Drivers
TOC Continued…
LIST OF TABLES
Table 1 Pharmacogenomics Industry Synopsis, 2017 – 2023
Table 2 Global Pharmacogenomics Market Estimates And Forecast, 2017 – 2023, (USD Million)
Table 3 Global Pharmacogenomics Market By Region, 2017 – 2023, (USD Million)
Table 4 Global Pharmacogenomics Market By Technology, 2017 – 2023, (USD Million)
Table 5 Global Pharmacogenomics Market By Application, 2017 – 2023, (USD Million)
Table 6 Global Pharmacogenomics Market By End Users, 2017 – 2023, (USD Million)
Continued…
Do You Have Specific Requirement? Ask To Our Experts @ https://www.marketresearchfuture.com/reports/pharmacogenomics-market-1177
LIST OF FIGURES
Figure 1 Research Process
Figure 2 Segmentation For Global Pharmacogenomics Market
Figure 3 Segmentation Market Dynamics For Global Pharmacogenomics Market
Figure 4 Global Pharmacogenomics Market Share, By Technology 2016
Figure 5 Global Pharmacogenomics Market Share, By Application 2016
Figure 6 Global Pharmacogenomics Market Share, By End Users, 2016
Continued..
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Statistical Report, Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact Us:
Market Research Future
Hadapsar, Pune – 411028
Maharashtra, India
Phone: +1 646 845 9312
Email: sales@marketresearchfuture.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Pharmacogenomics Market Potential, Dynamics, Share Value, Size Analysis and Outlook to 2023 – by Teva Pharmaceutical Industries Ltd., Assurex Health Inc., Future Science Group, Pathway Genomics, etc here
News-ID: 1481017 • Views: …
More Releases from Market Research Future

Global Small Boat Industry Sees Growing Demand Amid Rising Recreational Boating …
As per the latest analysis by Market Research Future, the Small Boats Market Size was estimated at 17.12 (USD Billion) in 2024. The Small Boats Market Industry is expected to grow from 17.88 (USD Billion) in 2025 to 26.41 (USD Billion) till 2034, at a CAGR (growth rate) is expected to be around 4.43% during the forecast period (2025 - 2034).
The global small boat industry is witnessing significant growth, driven…

Automotive Trim Market Attaining USD 193.22 Billion till 2034 | Innovations Rede …
As per the latest analysis by Market Research Future, the Automotive Trim Market Size was estimated at 140.30 (USD Billion) in 2024. The Automotive Trim Market Industry is expected to grow from 144.87 (USD Billion) in 2025 to 193.22 (USD Billion) till 2034, at a CAGR (growth rate) is expected to be around 3.25% during the forecast period (2025 - 2034).
The automotive industry is witnessing a significant transformation in vehicle…

Leading Automotive Technology Firms Expand Fuel Level Sensor Solutions for Next- …
As per the latest analysis by Market Research Future, Automotive Fuel Level Sensor Market Size was valued at USD 5,788.04 million in 2024. The Automotive Fuel Level Sensor market industry is projected to grow from USD 6,008.32 million in 2025 to USD 9,201.90 million by 2035, exhibiting a compound annual growth rate (CAGR) of 4.35% during the forecast period (2024 - 2035).
With the global automotive industry focused on precision,…

Valet Parking Technology Gains Momentum as Urban Mobility and Smart Infrastructu …
As per the latest analysis by Market Research Future, the Valet Parking Technology Market Size was estimated at 1.41 (USD Billion) in 2024. The Valet Parking Technology Market Industry is expected to grow from 1.63 (USD Billion) in 2025 to 6.01 (USD Billion) till 2034, at a CAGR (growth rate) is expected to be around 15.62% during the forecast period (2025 - 2034).
Valet parking technology is emerging as a transformative…
More Releases for Pharmacogenomics
Pharmacogenomics - Top Companies Regional and Data Analysis
Pharmacogenomics is a branch of science, which studies the role of gene over the activity of a drugs and hence helps the refreshers in predicting the response of novel as well as previously available therapies.
Get More Details with Sample PDF Copy @ https://www.theinsightpartners.com/sample/TIPRE00007564/?utm_source=OpenPR&utm_medium=10129
Major Companies operating in the Pharmacogenomics Market are:
• F. Hoffmann-la Roche Ltd
• Abbott
• Oxford Nanopore Technologies
• Thermo Fisher Scientific Inc.
• Illumina, Inc.
• QIAGEN
• Agilent Technologies, Inc.
• Myriad Genetics, Inc.
• Admera Health
Contact Us:
If you have any queries about…
Pharmacogenomics Market worth $5.8 billion by 2028
North America region is witnessing increasing investments and research activities in the field of drug discovery and development. The need for advanced therapies due to rising rate of cancer has contributed to growth of the pharmacogenomics market.
Pharmacogenomics Market [https://www.marketsandmarkets.com/Market-Reports/pharmacogenomics-market-142682251.html?utm_source=ABnewswire&utm_campaign=Paid&utm_content=Referral] in terms of revenue was estimated to be worth $3.5 billion in 2023 and is poised to reach $5.8 billion by 2028, growing at a CAGR of 10.6% from 2023 to…
Genetic Medicine: Unveiling the Power of Pharmacogenomics
Based on technology, the pharmacogenomics market is segmented into PCR, sequencing, microarray, gel electrophoresis, mass spectrometry, and others. The market for the PCR segment is subsegmented into real time PCR, standard PCR, and digital PCR. The PCR segment dominated the pharmacogenomics market in 2021 and is expected to register the highest CAGR during the forecast period.
Download Sample PDF Details at: https://www.theinsightpartners.com/sample/TIPRE00007564?utm_source=OpenPR&utm_medium=10776
The pharmacogenomics market is segmented on the basis of…
Complete PDF Guide On Pharmacogenomics [PDF]
According to our latest study on "Pharmacogenoics Market Forecast to 2028 - COVID-19 Impact and Global Analysis - by Technology, Application, and End User," the market is projected to reach US$ 14,107.80 million by 2028 from US$ 7,087.81 million in 2021; it is expected to grow at a CAGR of 10.3% from 2021 to 2028. The report highlights the key factors driving the market growth and prominent players with their…
Global Pharmacogenomics Market Size & Trends
According to a new market research report published by Global Market Estimates, the global pharmacogenomics market is projected to grow at a CAGR of 9.6% from 2023 to 2028.
The growth of the global pharmacogenomics market is driven by advancements in genomics and DNA sequencing technologies, the rising demand for personalized medicine, regulatory support from agencies like the FDA, cost-effectiveness through reduced adverse reactions, and a growing aging population with complex…
Global Pharmacogenomics Services Market Insights | 2022-2032
The Pharmacogenomics Services Market refers to the services provided by companies and laboratories that offer personalized medicine based on a patient's genetic makeup. Pharmacogenomics is the study of how an individual's genes affect their response to certain drugs, and the pharmacogenomics services market focuses on utilizing this knowledge to optimize drug therapy.
These services typically involve genetic testing to identify specific genetic variations that may impact a patient's response to certain…